Frequently Asked Questions
Orders
Simply browse the PrEP product page which includes oral medication and vaginal rings. Select your preferred medication and upload your prescription. Choose your payment method (medical aid or credit card) for a secure transaction.
Yes, you can order HIV Self-Testing Kits independently from our platform to monitor your HIV status.
Once your order is dispatched, you will receive a tracking link to monitor the delivery status.
The cost of delivery is R95 per delivery nationwide.
The delivery takes 2 working days.
The repeat prescription will be dispensed every 25 days.
Have your HIV Self-Testing Kit delivered to you
Don’t compromise your health. Order your self-testing kit today.
Confidentiality
Yes, we prioritise your privacy. All information provided during the ordering process is handled with the utmost confidentiality.
HIV Self-Testing Kits
Each HIV Self-Testing Kit is provided with clear instructions. Follow the steps provided in the kit, and if you have any questions, our customer support team is here to assist you.
Yes, you can order HIV Self-Testing Kits independently from our platform to monitor your HIV status.
Contact a healthcare provider to commence highly active anti-retroviral treatment.
PrEP
It’s important for individuals considering PrEP to consult with a healthcare professional who can assess their specific risk factors, discuss the potential benefits and risks, and monitor them regularly while on PrEP. Additionally, adherence to the prescribed regimen is crucial for the effectiveness of PrEP. Regular follow-up appointments and HIV testing are typically recommended for those using PrEP.
PrEP (Pre-Exposure Prophylaxis) is a medication that, when taken consistently, can significantly reduce the risk of acquiring HIV. It works by preventing the virus from establishing a permanent infection
Pre-Exposure Prophylaxis (PrEP) is indicated for individuals who are at a higher risk of acquiring HIV. This includes, but is not limited to, the following groups:
Men who have sex with men (MSM): MSM are considered a high-risk group due to the higher prevalence of HIV within this population.
Heterosexual individuals with high-risk partners: Individuals in serodiscordant relationships (where one partner is HIV-positive and the other is HIV-negative), those with multiple sexual partners, or those whose partners engage in high-risk behaviours may be candidates for PrEP.
Injection drug users: Individuals who use injection drugs and share needles or engage in other high-risk behaviours are at an increased risk of HIV.
Transgender individuals: Transgender individuals, particularly those engaging in high-risk behaviours, may benefit from PrEP.
Commercial sex workers: Individuals involved in sex work, where there is an increased risk of HIV exposure, may be candidates for PrEP.
Individuals with a history of sexually transmitted infections (STIs): A history of certain STIs may indicate a higher risk of HIV transmission.
Individuals with a partner with HIV: Individuals who have a partner known to be HIV-positive may consider PrEP as part of a comprehensive prevention strategy.
Known HIV-positive status: PrEP is specifically designed for individuals who are HIV-negative. It should not be used by those who are already living with HIV.
Renal impairment: Some PrEP medications can affect kidney function, so individuals with significant renal impairment may need adjustments in the choice of PrEP drugs or dosage. Regular monitoring is essential.
Bone mineral density concerns: Long-term use of tenofovir, a component of some PrEP medications, has been associated with decreased bone mineral density. This may be a consideration, particularly in individuals with existing bone health issues.
Hepatitis B co-infection: Individuals co-infected with hepatitis B may require careful monitoring, as discontinuing PrEP can lead to a flare-up of hepatitis B.
PEP
Post Exposure Prophylaxis (PEP) is a critical intervention to prevent HIV infection after potential exposure, this
underscores the urgency of accessing medication promptly after potential exposure to HIV. PEP should ideally commence within 72 hours, or three days, of the exposure incident to maximize its effectiveness. This critical window emphasizes the importance of swift action and underscores the need for streamlined access to PEP medication. Online pharmacy platforms like Prep Club offer a solution by providing a convenient avenue for individuals to obtain PEP medication promptly, ensuring that they can initiate treatment within the crucial timeframe. By reducing barriers to access and facilitating rapid delivery of medication, these platforms play a pivotal role in ensuring that individuals receive timely care, thereby minimizing the risk of HIV transmission and promoting better health outcomes.
